CORE

🇺🇦   make metadata, not war

    2 research outputs found

    Effect of Comorbidities on Response Outcomes with First-Line Tyrosine Kinase Inhibitors (TKIs), Dasatinib Versus Imatinib, in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Exploratory Post Hoc Analysis of DASISION

    Author
    Publication venue
    CIG MEDIA GROUP, LP
    Publication date
    Field of study
    No full text
    Archivio della ricerca- UniversitĂ  di Roma La Sapienza

    Impact of Comorbidities on Response Outcomes in Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with First-Line Dasatinib Versus Imatinib: Exploratory Post Hoc Analysis of DASISION

    Author
    Publication venue
    AMER SOC HEMATOLOGY
    Publication date
    Field of study
    No full text
    Archivio della ricerca- UniversitĂ  di Roma La Sapienza
    corecore